D-4517.2

· Ashvattha Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for D-4517.2, covering 2025-05-04 to 2025-05-04. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and PK of Subcutaneous D-4517.2 in Subjects With Wet AMD or DME [Phase 2]